EUVIMEDEUVIMED entdecken
Crossref

The burden of rheumatoid arthritis and low back pain in North Africa and Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019

Mahnaz Sanjari, Sima Noorali, Amir Hossein Behnoush iD, Sahar Saeedi Moghaddam, Noushin Fahimfar, Mohammadreza Azangou-Khyavy, Shakiba Yousefi, Narges Ebrahimi, Hossein Yarmohammadi, Mohammad-Mahdi Rashidi, Afshin Ostovar, Bagher Larijani

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Mahnaz Sanjari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Low Back Pain, Arthritis, Rheumatoid, Musculoskeletal Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rheumatoid arthritis (RA) and low back pain (LBP) are among the most prevalent musculoskeletal disorders (MSDs). The need for investigation of regional and local patterns of these two MSDs seems inevitable for better policy‐making. The current study presents updated results of the Global Burden of Disease (GBD) Study 2019 and reports the burden of RA and LBP in North Africa and Middle East (NAME) countries from 1990 to 2019.

Methods

Incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), disability‐adjusted life‐years (DALYs), and risk factors, including high body mass index, occupational ergonomic factors, and smoking, were extracted based on the GBD 2019 data.

Results

The age‐standardized prevalence and mortality of RA were 120.6 (95% uncertainty interval [95% UI] 107.0–135.7) and 0.1 (95% UI 0.1–0.2) per 100 000 population in 2019 with 28.3% (95% UI 25.5%–30.9%) increase and 7.5% (95% UI −37.5% to 32.5%) decrease since 1990, respectively. Turkey had the highest age‐standardized incidence, prevalence, and DALYs of RA in 2019. All RA burden measures were higher for women; however, the incidence was almost the same at ages greater than 65 years. The age‐standardized prevalence and DALYs of LBP were 7668.2 (95% UI 6798.0–8636.3) and 862 (95% UI 605.5–1153.3) in 2019, which had decreased by 5.8% (95% UI −7.4% to −4.3%) and 6.0% (95% UI −7.7% to −4.2%) since 1990, respectively. Moreover, although Turkey had the highest incidence and prevalence in 1990, Iran was at the top in 2019. The regional age‐standardized DALY rates due to RA and LBP attributed to smoking were 1.7 (95% UI 0.5–3.2) and 139.4 (95% UI 87.3–198.8) in 2019, respectively, which had decreased 2.2% (95% UI −19.2% to 13.7%) and 15.4% (95% UI −19.4% to −10.5%) since 1990, respectively.

Conclusion

RA still imposes a significant burden in the NAME region as the burden measures have increased from 1990 to 2019. On the other hand, regarding LBP, a decreasing pattern was observed. Differences among the countries and between ages and genders can have implications, and the results of this study may be helpful for policy‐makers in the NAME countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low Back PainArthritis, RheumatoidMusculoskeletal DiseasesHumansMaleFemaleGlobal Burden of DiseaseQuality-Adjusted Life YearsRisk FactorsAfrica, NorthernTurkeyIncidencePrevalenceGlobal Health

Stichwörter der Autor:innen

Global Burden of Disease StudyNorth Africa and Middle Eastincidencelow back painrheumatoid arthritis

Autor:innen und Institutionen

  • Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Kiel Institute for the World Economy, Kiel, Germany.
  • Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Medical Students Research Committee, Shahed University, Tehran, Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Amir Hossein Behnoush

Zitieren

APA

Sanjari, M., Noorali, S., Behnoush, A. H., Saeedi Moghaddam, S., Fahimfar, N., Azangou-Khyavy, M., Yousefi, S., Ebrahimi, N., Yarmohammadi, H., Rashidi, M. M., Ostovar, A., & Larijani, B. (2023). The burden of rheumatoid arthritis and low back pain in North Africa and Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14908

Vancouver

Sanjari M, Noorali S, Behnoush AH, Saeedi Moghaddam S, Fahimfar N, Azangou-Khyavy M, et al. The burden of rheumatoid arthritis and low back pain in North Africa and Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14908

BibTeX
@article{Sanjari2023,
  author = {Sanjari, Mahnaz and Noorali, Sima and Behnoush, Amir Hossein and Saeedi Moghaddam, Sahar and Fahimfar, Noushin and Azangou-Khyavy, Mohammadreza and Yousefi, Shakiba and Ebrahimi, Narges and Yarmohammadi, Hossein and Rashidi, Mohammad-Mahdi and Ostovar, Afshin and Larijani, Bagher},
  title = {The burden of rheumatoid arthritis and low back pain in North Africa and Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14908}
}
Kostenlos starten →